LabGenius Therapeutics

London, United Kingdom · Founded 2012 · Privately Held (backing)

Developer of next-generation protein-based therapeutics designed to address unmet needs like inflammatory bowel disease. LabGenius Therapeutics is based in London, United Kingdom and was founded in 2012. Its last reported valuation was $85.9 million in Jul 2025. It has raised $93.4 million.

Last reported valuation
$85.9M
Oct 2026
Priced at
—
Total raised
$93.4M
Last round
—

Who backs LabGenius Therapeutics?

35 investors
InvestorType
Innovate UKOther
Lux CapitalVenture capital
FelicisVenture capital
Octopus VenturesVenture capital
Kevin MooreAngel
Charles SonghurstOther
Acequia CapitalOther
AtomicoAsset manager
Inovia CapitalVenture capital
M VenturesVenture capital
+ 25 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

LabGenius Therapeutics investors

35 investors are on record for LabGenius Therapeutics, including Innovate UK, Lux Capital, Felicis and Octopus Ventures. By type, the record holds 8 venture capital firms and 2 private investors.

Free account
More of LabGenius Therapeutics with a free account
  • ·The complete investor list: 35 names
  • ·Watch LabGenius Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 35 firms already write checks for companies like LabGenius Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View